Notification close image
No new Notification messages
card image
Seshaasai Technologies Ltd IPO
Apply for the Seshaasai Technologies Ltd IPO through UPI in Just minutes
delete image
card image
Start your SIP with just ₹100
Choose from 4,000+ Mutual Funds on Bajaj Broking
delete image
card image
Open a Free Demat Account
Pay ZERO maintenance charges for the first year, get free stock picks daily, and more.
delete image
card image
Trade Now, Pay Later with up to 4x
Never miss a good trading opportunity due to low funds with our MTF feature.
delete image
card image
Track Market Movers Instantly
Stay updated with real-time data. Get insights at your fingertips.
delete image

How to Apply for the Modern Diagnostic & Research Centre Limited IPO: Step-by-Step Investment Guide

Modern Diagnostic & Research Centre Limited operates in the healthcare diagnostics segment, providing pathology and radiology services across multiple locations in India. The company offers diagnostic testing through walk-in centres, home sample collection services, and digital reporting systems. Its service portfolio caters to both individual patients and institutional clients, including hospitals, clinics, and other healthcare establishments, covering routine diagnostics as well as specialised testing requirements.

Applicants who wish to participate in the Modern Diagnostic & Research Centre Limited IPO can apply through an authorised trading platform or by using the ASBA facility provided by their banking institution. The application process generally involves logging into the trading or banking application, navigating to the IPO section, selecting the Modern Diagnostic & Research Centre Limited IPO, and entering the required lot quantity within the specified price band. Applicants must authorise the payment mandate through UPI or bank authentication before the cut-off time on the issue closing date. After submission, the application proceeds through exchange-regulated verification and allotment procedures, which determine the final allocation status.

For more details, visit the Modern Diagnostic & Research Centre Limited IPO page.

Modern Diagnostic & Research Centre Limited IPO Details and Objectives

Details

Information

IPO Date

December 31, 2025 to January 2, 2026

Issue Size

40,99,200 shares (agg. up to ₹37 Cr)

Price Band

₹85 to ₹90 per share

Lot Size

1600 shares

Listing At

BSE, SME

Market Maker

Spread X Securities Pvt. Ltd. 

Purpose of the IPO

  • Funding capital expenditure for purchase of medical equipment towards establishment of new diagnostic centre and labs

  • Funding Working Capital Requirement

  • Repayment of certain outstanding borrowings availed by the Company

  • General Corporate Purpose

Timeline of Modern Diagnostic & Research Centre Limited IPO

Event

Date

IPO Open Date

Wed, Dec 31, 2025

IPO Close Date

Fri, Jan 2, 2026

Tentative Allotment

Mon, Jan 5, 2026

Initiation of Refunds

Tue, Jan 6, 2026

Credit of Shares to Demat

Tue, Jan 6, 2026

Tentative Listing Date

Wed, Jan 7, 2026

Pricing & Lot Size of Modern Diagnostic & Research Centre Limited IPO

Price Band for the IPO

  •  ₹85 to ₹90 per share

Minimum Lot Size and Application Details

Application

Lots

Shares

Amount

Individual investors (Retail) (Min)

2

3,200

₹2,88,000

Individual investors (Retail) (Max)

2

3,200

₹2,88,000

S-HNI (Min)

3

4,800

₹4,32,000

S-HNI (Max)

6

9,600

₹8,64,000

B-HNI (Min)

7

11,200

₹10,08,000

Modern Diagnostic & Research Centre Limited IPO Application Process

The Modern Diagnostic & Research Centre Limited IPO application process can be completed online through your trading platform. Below is a step-by-step guide to applying for the IPO:

Step 1: Login to Your Trading Platform

Access your trading account using the broker's app or website.

Step 2: Navigate to the IPO Section

Go to the IPO section to view active IPO listings.

Step 3: Select the Open IPO and Click Apply

Locate Modern Diagnostic & Research Centre Limited IPO in the list of available IPOs and click the ‘Apply’ button.

Step 4: Enter the Quantity of Shares You Wish to Apply For

Specify the number of shares (lot size: 1600 shares) within the price band of ₹85 to ₹90 per share.

Step 5: Provide Your UPI ID

Enter your UPI ID for payment authorisation and ensure sufficient funds in your bank account.

Step 6: Confirm the Application

Review your application details and confirm the UPI mandate before 5 PM on the last application day.

Step 7: Complete the Process and Wait for Allotment

Submit the application and monitor the allotment status to check if shares have been allocated to you.

Shares Offered in Modern Diagnostic & Research Centre Limited IPO

The Modern Diagnostic & Research Centre Limited IPO includes a structured allocation of equity shares across investor categories such as anchor investors, qualified institutional buyers, non-institutional investors, and retail investors. The distribution below outlines the share allocation and relative proportion assigned to each category as part of the overall public issue.

Category

Shares Offered

Amount (Rs Cr)

Size (%)

Market Maker

2,06,000

1.86

5.04%

QIB

19,44,800

17.50

47.42%

- Anchor Investor

11,61,600

10.45

28.34%

- QIB (Ex Anchor)

7,82,400

7.04

19.09%

NII

5,85,600

5.27

14.29%

- bNII (bids above ₹10L)

3,90,200

3.51

9.52%

- sNII (bids below ₹10L)

1,95,200

1.76

4.76%

Retail

13,63,200

12.27

33.26%

Total

40,99,200

36.89

100%

Financial Health and Performance

Key Financial Metrics

  • Total Assets: Grew from ₹49.49 crore in FY24 to ₹77.86 crore as of June 2025.

  • Total income: Reached ₹22.67 crore in FY25, as compared to ₹68.67 crore in FY24.

  • Profit After Tax (PAT): Stood at ₹3.00 crore for June 2025 as compared to ₹5.79 crore in FY24.

  • Net Worth: Recorded at ₹23.72 crore in FY25 in comparison to ₹11.76 crore in FY24.

  • Reserves and surplus: Stood at ₹12.72 crore in FY25, as compared to ₹10.76 crore in FY24.

  • EBITDA: Stood at ₹5.86 crore in June 2025 in comparison to ₹11.05 crore in FY24.

Recent Performance and Growth Prospects

  • Modern Diagnostic & Research Centre Limited has reported an increase in its total asset base in the latest reporting period, indicating continued investment in infrastructure, equipment, and operational capabilities to support its diagnostic services network.

  • Variations in total income between reporting periods reflect changes in testing volumes, service mix, and timing of revenue recognition, which are typical in diagnostic operations influenced by patient demand and institutional business cycles.

  • The latest reported period shows a change in profit after tax and EBITDA compared to the previous financial year, highlighting shifts in operating margins, cost structures, and utilisation levels across diagnostic centres.

  • Growth in net worth and reserves suggests retention of earnings within the business, contributing to a strengthening of the company’s capital base despite fluctuations in income and profitability.

  • The company’s recent financial performance reflects characteristics common to healthcare diagnostics providers, where outcomes may vary across periods due to changes in demand patterns, service expansion, and operational scale.

  • Future growth prospects are linked to the company’s ability to expand its diagnostic service offerings, maintain service quality, and manage operational efficiency across pathology and radiology segments.

  • Ongoing demand for diagnostic testing, preventive health check-ups, and institutional healthcare services may continue to influence performance, alongside the company’s approach to capacity utilisation, cost management, and geographic presence.

Investment Risks and Opportunities

Potential Risks of Investing in the IPO

  • Modern Diagnostic & Research Centre Limited operates in the healthcare diagnostics segment, where testing volumes and revenue can fluctuate based on patient demand, referral patterns, and overall healthcare utilisation trends.

  • The company’s operations depend on the effective management of diagnostic centres, and factors such as equipment maintenance, staffing requirements, and regulatory compliance may affect service continuity and operating performance.

Opportunities and Growth Potential

  • Ongoing demand for diagnostic testing, preventive health check-ups, and specialised pathology and radiology services may support continued utilisation of the company’s diagnostic network.

  • The company’s presence across multiple locations and its mix of walk-in services, home sample collection, and institutional business provide opportunities to serve a broad range of diagnostic requirements across different customer segments.

Key Performance Indicator (KPI)

KPI

Values

ROE

55.21%

ROCE

36.18%

Debt/Equity

1.07

RoNW

43.27%

PAT Margin

11.51%

EBITDA Margin

23.04%

Price to Book Value

4.78

Modern Diagnostic & Research Centre Limited IPO Registrar & Lead Managers

Registrar

Lead Manager(s)

MUFG Intime India Pvt. Ltd.

Beeline Capital Advisors Pvt. Ltd.

Company Address of Modern Diagnostic & Research Centre Limited

Modern Diagnostic & Research Centre Ltd. Address Plot No H-64,1st Floor BLK-H, Bali Nagar City landmark near Khetar Pal Hospital, Ramesh Nagar, West Delhi West Delhi, New Delhi, 110015

Phone: 9999474297

Email: compliance@mdrcindia.com

Website: http://www.mdrcindia.com/

Conclusion

Modern Diagnostic & Research Centre Limited operates in the healthcare diagnostics space, offering pathology and radiology services through a network of diagnostic centres and laboratories. Its operations span direct patient services and institutional engagements, supported by infrastructure investments, equipment upgrades, and service expansion initiatives. The IPO outlines objectives related to funding capital expenditure, meeting working capital requirements, repayment of certain borrowings, and general corporate purposes, along with clearly defined issue timelines and pricing details.

Applications for the Modern Diagnostic & Research Centre Limited IPO can be submitted through authorised trading platforms or via the ASBA facility offered by banking institutions. The application process involves selecting the IPO, entering the applicable lot quantity, authorising the payment mandate through UPI or bank authentication, and completing the submission within the prescribed timeframe. The application then moves through exchange-regulated verification and allotment procedures, which determine the final allocation outcome.

Interested in more opportunities? Check out our Upcoming IPO section for new listings and don’t forget to check your Modern Diagnostic & Research Centre IPO allotment status.

Frequently Asked Questions

No result found

search icon

Read More Blogs

Disclaimer :

The information on this website is provided on "AS IS" basis. Bajaj Broking (BFSL) does not warrant the accuracy of the information given herein, either expressly or impliedly, for any particular purpose and expressly disclaims any warranties of merchantability or suitability for any particular purpose. While BFSL strives to ensure accuracy, it does not guarantee the completeness, reliability, or timeliness of the information. Users are advised to independently verify details and stay updated with any changes. The securities are quoted as an example and not as a recommendation. Past performance is not necessarily a guide to future performance.

The information provided on this website is for general informational purposes only and is subject to change without prior notice. BFSL shall not be responsible for any consequences arising from reliance on the information provided herein and shall not be held responsible for all or any actions that may subsequently result in any loss, damage and or liability. Interest rates, fees, and charges etc., are revised from time to time, for the latest details please refer to our Pricing page.

Neither the information, nor any opinion contained in this website constitutes a solicitation or offer by BFSL or its affiliates to buy or sell any securities, futures, options or other financial instruments or provide any investment advice or service.

BFSL is acting as distributor for non-broking products/ services such as IPO, Mutual Fund, Insurance, PMS, and NPS. These are not Exchange Traded Products. For more details on risk factors, terms and conditions please read the sales brochure carefully before investing.

Investments in the securities market are subject to market risk, read all related documents carefully before investing. This content is for educational purposes only. Securities quoted are exemplary and not recommendatory.

[ Read More ]

For more disclaimer, check here : https://www.bajajbroking.in/disclaimer

Our Secure Trading Platforms

Level up your stock market experience: Download the Bajaj Broking App for effortless investing and trading

Bajaj Broking App Download

11 lakh+ Users

icon-with-text

4.8 App Rating

icon-with-text

4 Languages

icon-with-text

₹7,900+ Cr MTF Book

icon-with-text
banner-icon

Open Your Free Demat Account

Enjoy low brokerage on delivery trades

+91

|

Please Enter Mobile Number

Open Your Free Demat Account

Enjoy low brokerage on delivery trades

+91

|